•
§ 823. Registration requirements.
•
(a) Manufacturers of controlled substances in schedule I or II.
•
(b) Distributors of controlled substances in schedule I or II.
•
(c) Limits of authorized activities.
•
(d) Manufacturers of controlled substances in schedule III, IV, or V.
•
(e) Distributors of controlled substances in schedule III, IV, or V.
•
(f) Research by practitioners; pharmacies; research applications;construction of Article 7 of the Convention on Psychotropic Substances.
•
(g) Practitioners dispensing narcotic drugs for narcotic treatment; annualregistration; separate registration; qualifications.
•
(h) Applicants for distribution of list I chemicals.
•
§ 824. Denial, revocation, or suspension of registration.
•
(a) Grounds.
•
(b) Limits of revocation or suspension.
•
(c) Service of show cause order; proceedings.
•
(d) Suspension of registration in cases of imminent danger.
•
(e) Suspension and revocation of quotas.
•
(f) Disposition of controlled substances or list I chemicals.
•
(g) Seizure or placement under seal of controlled substances or list Ichemicals.
•
§ 825. Labeling and packaging.
•
(a) Symbol.
•
(b) Unlawful distribution without identifying symbol.
•
(c) Warning on label.
•
(d) Containers to be securely sealed.
•
§ 826. Production quotas for controlled substances.
•
(a) Establishment of total annual needs.
•
(b) Individual production quotas; revised quotas.
•
(c) Manufacturing quotas for registered manufacturers.
•
(d) Quotas for registrants who have not manufactured controlledsubstance during one or more preceding years.
•
(e) Quota increases.
•
(f) Incidental production exception.
•
§ 827. Records and reports of registrants.
•
(a) Inventory.
•
(b) Availability of records.
•
(c) Nonapplicability.
•
(d) Periodic reports to Attorney General.
•
(e) Reporting and recordkeeping requirements of drug conventions.
•
(f) Investigational uses of drugs; procedures.
•
(g) Change of address.
•
•
(a) Unlawful distribution of controlled substances.
•
(b) Nonapplicability of provisions.
Leave a Comment